ES2108272T3 - Procedimiento de fabricacion de nanocapsulas con pared a base de proteinas reticuladas; nanocapsulas asi obtenidas y composiciones cosmeticas farmaceuticas y alimentarias que comprenden la aplicacion. - Google Patents

Procedimiento de fabricacion de nanocapsulas con pared a base de proteinas reticuladas; nanocapsulas asi obtenidas y composiciones cosmeticas farmaceuticas y alimentarias que comprenden la aplicacion.

Info

Publication number
ES2108272T3
ES2108272T3 ES93909334T ES93909334T ES2108272T3 ES 2108272 T3 ES2108272 T3 ES 2108272T3 ES 93909334 T ES93909334 T ES 93909334T ES 93909334 T ES93909334 T ES 93909334T ES 2108272 T3 ES2108272 T3 ES 2108272T3
Authority
ES
Spain
Prior art keywords
proteins
nanocapsules
reticulated
wall
application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93909334T
Other languages
English (en)
Inventor
Eric Perrier
Alain Huc
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Beauty Care Solutions France SAS
Original Assignee
Coletica SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coletica SA filed Critical Coletica SA
Application granted granted Critical
Publication of ES2108272T3 publication Critical patent/ES2108272T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/06—Making microcapsules or microballoons by phase separation
    • B01J13/14—Polymerisation; cross-linking
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9771—Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5169—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/926—Topical chemical, e.g. cosmetic or sunscreen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • General Preparation And Processing Of Foods (AREA)

Abstract

LA INVENCION CONCIERNE A UN PROCESO DE FABRICACION DE NANOCAPSULAS CUYA PARED ES A BASE DE PROTEINAS RETICULADAS. ESTE PROCESO COMPRENDE LA PREPARACION DE EMULSIONES DE DICHAS PROTEINAS Y UNA RETICULACION DE DICHAS PROTEINAS POR UN AGENTE RETICULANTE QUE COMPRENDE GRUPOS REACTIVOS CAPACES DE REACCIONAR CON GRUPOS REACTIVOS DE LAS PROTEINAS, EN PARTICULAR GRUPOS ACILABLES, DE MANERA QUE REALICEN UNA REACCION DE RETICULACION INTERFACIAL ENTRE LAS PROTEINAS Y EL AGENTE RETICULANTE PARA FORMAR CAPSULAS CUYA PARED ES UNA PARED A BASE DE PROTEINAS RETICULADAS POR EL AGENTE RETICULANTES, Y CARACTERIZADO EN QUE SE PREPARA UNA EMULSION MUY FINA DE DICHAS PROTEINAS AJUSTANDO LA TENSION SUPERFICIAL ENTRE LAS FASES LIQUIDAS PRESENTES. SE OBTIENEN ASI NANOCAPSULAS BIOCOMPATIBLES, BIODEGRADABLES Y QUE OFRECEN UN MEJOR EFECTO DE RETARDO.
ES93909334T 1991-10-31 1992-10-27 Procedimiento de fabricacion de nanocapsulas con pared a base de proteinas reticuladas; nanocapsulas asi obtenidas y composiciones cosmeticas farmaceuticas y alimentarias que comprenden la aplicacion. Expired - Lifetime ES2108272T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9113522A FR2683159B1 (fr) 1991-10-31 1991-10-31 Procede de fabrication de nanocapsules a paroi a base de proteines reticulees; nanocapsules ainsi obtenues et compositions cosmetiques, pharmaceutiques et alimentaires en comportant application.

Publications (1)

Publication Number Publication Date
ES2108272T3 true ES2108272T3 (es) 1997-12-16

Family

ID=9418551

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93909334T Expired - Lifetime ES2108272T3 (es) 1991-10-31 1992-10-27 Procedimiento de fabricacion de nanocapsulas con pared a base de proteinas reticuladas; nanocapsulas asi obtenidas y composiciones cosmeticas farmaceuticas y alimentarias que comprenden la aplicacion.

Country Status (9)

Country Link
US (1) US6303150B1 (es)
EP (1) EP0611326B1 (es)
JP (1) JPH07504115A (es)
AT (1) ATE156386T1 (es)
CA (1) CA2122260A1 (es)
DE (1) DE69221498T2 (es)
ES (1) ES2108272T3 (es)
FR (1) FR2683159B1 (es)
WO (1) WO1993008908A1 (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5916596A (en) * 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
FR2725620A1 (fr) * 1994-10-14 1996-04-19 Coletica Principe actif bifonctionnel, son procede de preparation, et ses applications en pharmacie, en cosmetique ou en agroalimentaire
US8137684B2 (en) 1996-10-01 2012-03-20 Abraxis Bioscience, Llc Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
JP4135995B2 (ja) * 1997-07-15 2008-08-20 ビーエーエスエフ ビューティ ケア ソリューションズ フランス エスエーエス 架橋した植物タンパク質の粒子、特にマイクロ粒子又はナノ粒子、調製方法、及び、これを含む化粧用、医薬用又は食品用の組成物
EP0934773B1 (en) 1998-02-06 2004-02-04 Seiwa Kasei Co., Ltd. Microcapsule having a specific wall and method for producing the same
FR2777193B1 (fr) * 1998-04-14 2001-06-08 Coletica Particule a groupement hydroxamique chelatante d'ions metalliques et leur utilisation en cosmetique ou en pharmacie
US20040126900A1 (en) * 2001-04-13 2004-07-01 Barry Stephen E High affinity peptide- containing nanoparticles
US7001987B2 (en) * 2002-04-22 2006-02-21 Keraplast Technologies, Ltd. Hydrogel with controllable mechanical, chemical, and biological properties and method for making same
US6914126B2 (en) * 2002-04-10 2005-07-05 Keraplast Technologies, Ltd. Methods for producing, films comprising, and methods for using heterogenous crosslinked protein networks
US20040120910A1 (en) * 2002-04-10 2004-06-24 Dyke Mark Van Methods for producing, films comprising, and methods for using heterogeneous crosslinked protein networks
PL217626B1 (pl) 2002-07-18 2014-08-29 Helix Biopharma Corp Kompozycja farmaceutyczna do zastosowania w leczeniu raka
FR2848847B1 (fr) * 2002-12-18 2005-10-14 Coletica Composition cosmetique ou dermopharmaceutique comprenant une enzyme insoluble en milieu aqueux, ainsi que ses utilisations
EP1454610A1 (de) * 2003-03-06 2004-09-08 Cognis France S.A. Kosmetische und/oder pharmazeutische Zubereitungen mikroverkapselte Pflanzenextrakte enthaltend
DE602004024982D1 (de) * 2003-05-28 2010-02-25 Unilever Nv Nahrungsmittel enthaltend sättigungsmittel
AU2004243536B2 (en) * 2003-05-28 2007-10-11 Unilever Plc Satiety enhancing food products
US20050084513A1 (en) * 2003-10-21 2005-04-21 Board Of Regents Nanocoating for improving biocompatibility of medical implants
EP1709169B1 (en) * 2004-01-28 2008-09-10 Csir Stabilization of enzymes
US20070190101A1 (en) * 2004-03-31 2007-08-16 Chunlin Yang Flowable bone grafts
DE602005002654T2 (de) * 2005-08-01 2008-06-19 Technische Universität München Prozess zur Herstellung von Nano- und Mikrokapseln aus Spinnenseidenprotein
EP1979055A2 (de) * 2006-01-20 2008-10-15 Basf Se Verwendung von protein-microbeads in der kosmetik
FR2910286B1 (fr) 2006-12-20 2009-04-17 Oreal Composition comprenant des composes silicones encapsules
JP2008201767A (ja) * 2007-01-24 2008-09-04 Fujifilm Corp 頭髪用組成物
US20080175807A1 (en) 2007-01-24 2008-07-24 Fujifilm Corporation Composition for hair
JP2008255020A (ja) * 2007-04-02 2008-10-23 Fujifilm Corp 抗老化皮膚外用剤
US20100055246A1 (en) * 2008-08-28 2010-03-04 Dong June Ahn Nutrition delivery capsules for functional foods
US20100055187A1 (en) * 2008-08-28 2010-03-04 Dong June Ahn Nanovitamin synthesis
FR2943544B1 (fr) * 2009-03-31 2012-04-20 Univ Angers Procede de preparation de capsules lipidiques fonctionnalisees.
EP2429489A4 (en) * 2009-05-11 2015-07-22 Elc Man Llc COSMETIC COMPOSITIONS WITH REINFORCED HUMIDITY
JP2012526845A (ja) 2009-05-13 2012-11-01 ケラプラスト テクノロジーズ， リミテッド バイオポリマー材料
US8716219B2 (en) * 2009-07-07 2014-05-06 Sabanci University Crosslinked protein nanocrystals, crosslinked protein nanoaggregates and method of preparation thereof
JP6108382B2 (ja) * 2012-09-04 2017-04-05 国立大学法人九州大学 新規イオン液体およびその用途
WO2016057809A1 (en) * 2014-10-10 2016-04-14 Therakine Mg stearate - based composite nanoparticles, methods of preparation and applications
BR112017011641B1 (pt) 2014-12-02 2021-02-17 Silk Therapeutics, Inc. artigo que possui um revestimento
US11931422B2 (en) 2015-01-23 2024-03-19 Helix Biopharma Corporation Antibody-urease conjugates for therapeutic purposes
EP3081288B1 (en) * 2015-04-15 2019-07-24 Agfa Nv Self-dispersing capsules
KR20180072664A (ko) 2015-07-14 2018-06-29 실크 테라퓨틱스, 인코퍼레이티드 실크 성능 의류와 제품들 및 이의 제조 방법
CN105628553B (zh) * 2015-12-22 2020-08-07 贵州中烟工业有限责任公司 一种判断成膜液使用终点的方法
EP3688018A4 (en) 2017-09-27 2021-07-07 Evolved by Nature, Inc. SILK COVERED FABRICS, RELATED PRODUCTS AND PREPARATION PROCESSES
JP2023538276A (ja) * 2020-08-06 2023-09-07 シムライズ アーゲー マイクロカプセルの調製プロセス

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4273672A (en) * 1971-08-23 1981-06-16 Champion International Corporation Microencapsulation process
AU495261B2 (en) * 1974-09-18 1977-03-17 Pharmaceutical Society of Victoria and Peter Speiser Nanoparticles and method of preparing same
US4871716A (en) * 1986-02-04 1989-10-03 University Of Florida Magnetically responsive, hydrophilic microspheres for incorporation of therapeutic substances and methods of preparation thereof
US5069936A (en) * 1987-06-25 1991-12-03 Yen Richard C K Manufacturing protein microspheres
JPS6418439A (en) * 1987-07-14 1989-01-23 Nippon Oils & Fats Co Ltd Powdery fat coated with crosslinked coating and its manufacture
US5055300A (en) * 1988-06-17 1991-10-08 Basic Bio Systems, Inc. Time release protein
US5395620A (en) 1989-01-31 1995-03-07 Coletica Biodegradable microcapsules having walls composed of crosslinked atelocollagen and polyholoside
FR2642329B1 (fr) 1989-01-31 1991-05-24 Bioetica Sa Utilisation de solutions d'atelocollagene et de glycosaminoglycannes pour la fabrication de microcapsules, microcapsules ainsi realisees, procedes de fabrication de telles microcapsules et compositions cosmetiques ou pharmaceutiques ou alimentaires en contenant

Also Published As

Publication number Publication date
WO1993008908A1 (fr) 1993-05-13
FR2683159A1 (fr) 1993-05-07
ATE156386T1 (de) 1997-08-15
EP0611326A1 (fr) 1994-08-24
JPH07504115A (ja) 1995-05-11
CA2122260A1 (en) 1993-05-13
DE69221498T2 (de) 1998-02-05
EP0611326B1 (fr) 1997-08-06
FR2683159B1 (fr) 1994-02-25
US6303150B1 (en) 2001-10-16
DE69221498D1 (de) 1997-09-11

Similar Documents

Publication Publication Date Title
ES2108272T3 (es) Procedimiento de fabricacion de nanocapsulas con pared a base de proteinas reticuladas; nanocapsulas asi obtenidas y composiciones cosmeticas farmaceuticas y alimentarias que comprenden la aplicacion.
DK330186A (da) Fremgangsmaade til fremstilling af smaa, kugleformede polymerpartikler
BR9603148A (pt) Método para preparar polímeros em emulsão hidrofobicamente modificados polímeros assim obtidos e composições transportadas por água para revestimento contendo os polímeros
MY113418A (en) Recirculating a portion of high internal phase emulsions prepared in a continuous process
RU95109875A (ru) Способ получения пористого сшитого полимерного материала
ATE385784T1 (de) Wässrige, viskose, klare oder nicht klare zusammensetzungen zur herstellung von weichkapseln und hartkapseln, und herstellungsverfahren von filmen für diese kapseln
ES524518A0 (es) Un procedimiento para preparar un agente anti-inflamatorio
ATE168534T1 (de) Verfahren zur herstellung von futterpellets
ES534974A0 (es) Procedimiento para la preparacion de masas cosmeticas anhidras
ATE116280T1 (de) Verfahren zur herstellung von polyglycerinen und polyglycerinestern.
FR2715306B1 (fr) Composition cosmétique ou dermopharmaceutique sous forme de pâte souple et procédé de préparation de ladite composition.
DE69615453D1 (de) Verfahren zur Herstellung von mikrokapselhaltigen Zusammensetzungen
BR8905509A (pt) Processo,processo de moldagem,processo para a preparacao de um molde e aparelhagem para a deposicao de uma mistura de fluido super-critico contendo um agente de liberacao
DE69033073D1 (de) Haarpflege- und Fixierungsmittel
EP0426391A3 (en) Synthetic resin emulsion, process for producing it and coating compositions comprising it
DE3262808D1 (en) Process for producing a spread starting from a bimodal dispersed phase
DE69618703D1 (de) Verfahren zur Herstellung von Polysiloxanen
WO1990012055A3 (fr) Procede de reticulation du collagene par le diphenylphosphorylazide, collagene reticule ainsi obtenu et biomateriaux a base de collagene ainsi reticules
DE69609462D1 (de) Verfahren zur kontinuierlichen Herstellung von Organopolysiloxanemulsionen
EP0780422A3 (en) Silicone emulsions which crosslink by Michael addition reactions
CA2156102A1 (en) Microcapsule flavor delivery system
ATE200858T1 (de) Haarbehandlungsmittel und verfahren zur haarbehandlung
WO1999006011A3 (de) Schellackhaltiges kosmetisches produkt
SE9401557D0 (sv) Process for the preparation of dry processed particles, dry peocessed particles thus obtained and pharmaceutical compositions containing such particles
EE9700157A (et) Meetod 4,10-diatsetoksü-2a-bensoüüloksü-5ß,20 -epoksü-1,7ß-dihüdroksü-9-okso-taks-11-een-13a-üüli (2R,3S)-3-bensoüülamino-2-hüdroksü-3-fenüülpropionaadi trihüdraadi valmistamiseks

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 611326

Country of ref document: ES